GetTopicDetailResponse(id=3f8b8503cb, topicName=HBcrAg, introduction=HBcrAg, content=null, image=null, comments=0, allHits=1098, url=https://h5.medsci.cn/topic?id=8503, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=43904, tagList=[TagDto(tagId=43904, tagName=HBcrAg)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2243275, encodeId=119d22432e550, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【AASLD2024速遞】慢乙肝臨床治愈持久性相關(guān)因素探索：循環(huán)CCR7(LO)PD-1(HI)濾泡輔助T細(xì)胞和HBcrAg水平, objectType=article, longId=851389, objectId=fd3985138939, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716173655527_5579292.jpg, objectUrl=/article/show_article.do?id=fd3985138939, replyNumber=0, likeNumber=42, createdTime=2024-12-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=fd3985138939, moduleTitle=【AASLD2024速遞】慢乙肝臨床治愈持久性相關(guān)因素探索：循環(huán)CCR7(LO)PD-1(HI)濾泡輔助T細(xì)胞和HBcrAg水平, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fd3985138939)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190994, encodeId=734d219099406, content=<a href='/topic/show?id=2d305285e9f' target=_blank style='color:#2F92EE;'>#恩替卡韋#</a> <a href='/topic/show?id=b41a603616e' target=_blank style='color:#2F92EE;'>#替諾福韋酯#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【期刊導(dǎo)讀】恩替卡韋或替諾福韋酯停藥后累積臨床復(fù)發(fā)率超50%，停藥后HBcrAg的動(dòng)態(tài)變化可預(yù)測(cè), objectType=article, longId=815455, objectId=bee481545527, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=bee481545527, replyNumber=0, likeNumber=84, createdTime=2024-03-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bee481545527, moduleTitle=【期刊導(dǎo)讀】恩替卡韋或替諾福韋酯停藥后累積臨床復(fù)發(fā)率超50%，停藥后HBcrAg的動(dòng)態(tài)變化可預(yù)測(cè), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bee481545527)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
